First siRNA Therapy Approved for Myasthenia Gravis | HappeningNow.news

Health · 11 views

First siRNA Therapy Approved for Myasthenia Gravis

(MedPage Today) -- The FDA approved subcutaneous cemdisiran (Livsayis), a small interfering RNA (siRNA) therapy, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody-positive, Regeneron…

Source Summary Published 3h 45m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 11 Community interest
Brief read Under 1 min brief 30 words

Summary

(MedPage Today) -- The FDA approved subcutaneous cemdisiran (Livsayis), a small interfering RNA (siRNA) therapy, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody-positive, Regeneron announced

Read original at MedPage Today

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page